glp 1 for liver health Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans Did you know fatty liver

The threshold theory for the actions of UA on the -cells hypothesizes that the detrimental effects of UA occurs above a given concentration

It is metabolized by the cytochrome P450 family (more specifically CYP2D6) to active metabolites such as endoxifen (4-OH-N-desmethyl-tamoxifen)

Consistency beats size: a modest protein breakfast every day protects muscle better than an occasional big one

By removing the psychological and practical barriers associated with injectable treatments, oral GLP-1s have the potential to reposition obesity care as a routine, chronic intervention rather than a specialist-led, escalation therapy

Huang H, Zhao Y, Liu Z, Zhang Y, Zhang H, Fu T, et al

Follow-up labs are typically recommended at 3 months, 6 months, and then every 6 to 12 months during treatment